CNP ASSURANCES financials
CNP ASSURANCES
Country: FR Reporting currency: EUR Latest annual report: 2025-12-31
LEI:
969500QKVPV2H8UXM738 Financial statements
(EUR, as reported — unscaled; 109 line items across 2 annual periods)
| Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Operating profit (EBIT) | €2.93B | €3.16B |
| Finance costs | €214.2M | €212.5M |
| Income tax expense | €955.8M | €1.02B |
| Profit for the year | €1.82B | €1.96B |
| — attributable to owners | €1.51B | €1.61B |
| — attributable to NCI | €305.1M | €350.2M |
| Total comprehensive income | €2.30B | €1.11B |
| Cash flow statement | ||
| Net cash from operating activities | €4.96B | €706.9M |
| Net cash from investing activities | -€2.97B | €1.84B |
| Net cash from financing activities | -€1.49B | -€2.99B |
| Dividends paid | €1.21B | €2.72B |
| Proceeds from borrowings | €496.3M | €500.1M |
| Repayments of borrowings | €500.0M | €493.6M |
| Balance sheet | ||
| Total assets | €431.36B | €434.75B |
| Property, plant & equipment | €351.8M | €411.8M |
| Intangible assets & goodwill | €2.84B | €3.02B |
| Cash & equivalents | €1.70B | €1.45B |
| Total equity | €22.17B | €21.11B |
| — attributable to owners | €19.12B | €17.52B |
| Non-controlling interests | €3.04B | €3.59B |
| Deferred tax liabilities | €763.9M | €764.9M |
| Derived metrics | ||
| Return on equity | 8.2% | 9.3% |
| Cash conversion ratio | 2.72× | 0.36× |
| Other reported items | ||
| Adjustments For Depreciation and Amortisation Expense | €203.1M | €229.2M |
| Adjustments For Fair Value Gains Losses | -€9.52B | -€7.18B |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €71.8M | €17.1M |
| Adjustments For Provisions | -€500.0K | -€13.1M |
| Adjustments To Reconcile Profit Loss Other Than Changes In Working Capital | -€11.34B | -€9.21B |
| Bank Overdrafts Classified As Cash Equivalents | €433.0M | €491.1M |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €1.27B | €960.0M |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €812.5M | €0 |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €0 | -€41.4M |
| Comprehensive Income Attributable To Noncontrolling Interests | €349.7M | -€181.6M |
| Comprehensive Income Attributable To Owners of Parent | €1.95B | €1.29B |
| Current Tax Assets | €135.9M | €123.2M |
| Current Tax Liabilities | €94.6M | €118.6M |
| Deferred Tax Assets | €1.04B | €972.3M |
| Derivative Financial Assets Held For Trading | €998.8M | €986.1M |
| Derivative Financial Liabilities Held For Trading | €410.2M | €640.5M |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners | €735.0M | — |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | €1.07 | — |
| Dividends Received Classified As Operating Activities | €63.1M | €85.6M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €25.7M | €11.4M |
| Equity and Liabilities | €431.36B | €434.75B |
| Finance Income Expenses From Reinsurance Contracts Held Recognised In Profit Or Loss | -€64.7M | €97.2M |
| Financial Assets At Amortised Cost | €5.00B | €3.29B |
| Financial Assets At Fair Value Through Other Comprehensive Income | €202.54B | €201.02B |
| Gain Loss Arising From Derecognition of Financial Assets Measured At Amortised Cost | €1.0M | €100.0K |
| Gains Losses On Cash Flow Hedges Before Tax | -€104.0M | €43.0M |
| Gains Losses On Financial Assets Measured At Fair Value Through Other Comprehensive Income Before Tax | -€1.87B | -€163.0M |
| Impairment Loss Impairment Gain and Reversal of Impairment Loss Determined In Accordance With IFRS9 | €17.3M | €17.0M |
| Income Expenses From Reinsurance Contracts Held Other Than Finance Income Expenses | -€59.7M | -€58.7M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss | -€304.1M | -€42.7M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss | €484.7M | €47.3M |
| Income Taxes Paid Refund Classified As Operating Activities | €1.27B | €896.8M |
| Increase Decrease In Cash and Cash Equivalents Discontinued Operations | -€219.8M | -€193.7M |
| Increase Decrease Through Changes In Fair Values Liabilities Arising From Financing Activities | -€111.7M | €49.7M |
| Increase Decrease Through Financing Cash Flows Liabilities Arising From Financing Activities | -€3.6M | €6.4M |
| Increase Decrease Through Transfers and Other Changes Equity | -€32.5M | €36.0M |
| Increase Decrease Through Treasury Share Transactions | €0 | €0 |
| Insurance Contracts Issued That Are Assets | €375.0M | €333.2M |
| Insurance Contracts Issued That Are Liabilities | €376.95B | €363.16B |
| Insurance Finance Income Expenses From Insurance Contracts Issued Recognised In Profit Or Loss | -€16.68B | -€14.53B |
| Insurance Revenue | €10.74B | €11.02B |
| Insurance Service Expenses From Insurance Contracts Issued | €7.99B | €8.07B |
| Insurance Service Result | €2.69B | €2.89B |
| Interest Paid Classified As Financing Activities | €270.0M | €296.8M |
| Interest Revenue Calculated Using Effective Interest Method | €203.7M | -€374.4M |
| Investment Accounted For Using Equity Method | €1.09B | €1.10B |
| Investment Contracts Liabilities | €1.89B | €2.02B |
| Investment Property | €5.87B | €6.11B |
| Issued Capital | €686.6M | €686.6M |
| Liabilities Arising From Financing Activities | €8.61B | €8.73B |
| Liabilities Included In Disposal Groups Classified As Held For Sale | €90.9M | €16.28B |
| Loans Received | €89.8M | €90.1M |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €142.3M | €17.29B |
| Other Adjustments For Noncash Items | -€484.4M | €11.4M |
| Other Comprehensive Income | €481.6M | -€846.3M |
| Other Comprehensive Income Before Tax Cash Flow Hedges | €19.1M | -€36.9M |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | €900.0K | -€971.0M |
| Other Comprehensive Income Before Tax Financial Assets Measured At Fair Value Through Other Comprehensive Income | -€2.07B | -€871.6M |
| Other Comprehensive Income Before Tax Gains Losses From Investments In Equity Instruments | €1.87B | €203.0M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €5.6M | -€17.6M |
| Other Comprehensive Income Before Tax Insurance Finance Income Expenses From Insurance Contracts Issued Excluded From Profit Or Loss That Will Be Reclassified To Profit Or Loss | €827.3M | €845.5M |
| Other Comprehensive Income Before Tax Insurance Finance Income Expenses From Insurance Contracts Issued Excluded From Profit Or Loss That Will Not Be Reclassified To Profit Or Loss | €0 | €0 |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -€909.5M | -€984.4M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | €1.39B | €138.0M |
| Other Liabilities | €5.32B | €5.16B |
| Other Provisions | €241.0M | €242.1M |
| Other Receivables | €5.79B | €7.62B |
| Proceeds From Issue of Regulatory Capital Equity | €0 | €14.9M |
| Proceeds From Sales of Investment Property | €178.5M | €415.8M |
| Proceeds From Sales Or Maturity of Financial Instruments Classified As Investing Activities | €155.66B | €167.63B |
| Profit Loss From Discontinued Operations | -€12.9M | -€26.3M |
| Purchase of Financial Instruments Classified As Investing Activities | €159.52B | €166.06B |
| Purchase of Investment Property | €34.0M | €79.2M |
| Reclassification Adjustments On Cash Flow Hedges Before Tax | -€123.0M | €79.8M |
| Reclassification Adjustments On Financial Assets Measured At Fair Value Through Other Comprehensive Income Before Tax | €206.4M | €708.6M |
| Reinsurance Contracts Held That Are Assets | €5.74B | €5.98B |
| Reinsurance Contracts Held That Are Liabilities | €3.0M | €1.9M |
| Repayments of Regulatory Capital Equity | €0 | €0 |
| Repurchase Agreements and Cash Collateral On Securities Lent | €15.74B | €17.06B |
| Reserve of Cash Flow Hedges | €55.8M | €42.8M |
| Reserve of Exchange Differences On Translation | -€1.41B | -€1.39B |
| Reserve of Remeasurements of Defined Benefit Plans | -€79.4M | -€83.6M |
| Retained Earnings Profit Loss For Reporting Period | €1.51B | €1.61B |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €92.2M | €95.0M |
| Share Premium | €1.74B | €1.74B |
| Subordinated Liabilities At Amortised Cost | €6.70B | €7.34B |
Methodology
Every line item above is a fact tagged in CNP ASSURANCES's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.